Filing Details
- Accession Number:
- 0001209191-16-136307
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-10 16:16:02
- Reporting Period:
- 2016-08-08
- Filing Date:
- 2016-08-10
- Accepted Time:
- 2016-08-10 16:16:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
917520 | Integra Lifesciences Holdings Corp | IART | Laboratory Analytical Instruments (3826) | 510317849 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1323134 | J Peter Arduini | 311 C Enterprise Drive Plainsboro NJ 08536 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-08-08 | 4,009 | $84.77 | 29,602 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2016-08-08 | 7,991 | $27.78 | 37,593 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-08-08 | 7,991 | $84.19 | 29,602 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2016-08-09 | 12,009 | $27.78 | 41,611 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-08-09 | 12,009 | $84.65 | 29,602 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2016-08-08 | 7,991 | $0.00 | 7,991 | $27.78 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2016-08-09 | 12,009 | $0.00 | 12,009 | $27.78 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
207,803 | 2020-03-01 | No | 4 | M | Direct | |
195,794 | 2020-03-01 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- The price shown above represents the weighted average price of the shares sold. The range of sale prices was $84.50 to $85.07.
- The price shown above represents the weighted average price of the shares sold. The range of sale prices was $83.90 to $84.61.
- The price shown above represents the weighted average price of the shares sold. The range of sale prices was $84.20 to $85.12.
- One-third of the stock options vested on the first anniversary of the grant date which is March 1, 2012 and thereafter with respect to the remaining two-thirds which vested in monthly installments through the 3rd anniversary of the grant date.
- This option was previously reported as covering 206,719 shares at an exercise price of $32.11 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015.